IMBiotechnologies produces Ekboi Embolization Microspheres, a biodegradable embolic agent that is detectable by ultrasound. It is approved in the U.S. for treatment of unresectable/inoperable hypervascularized tumors.
Through the new partnership, Embol will be able to provide Ekobi microspheres to its ASC partners, according to a Feb. 21 press release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
